Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB): a meta-analysis

被引:0
|
作者
Flacco, M. E. [1 ]
Manzoli, L. [2 ]
Rosso, A. [3 ]
Marzuillo, C. [3 ]
Bergamini, M. [4 ]
Stefanati, A. [4 ]
Villari, P. [3 ]
Ricciardi, W. [5 ]
Ioannidis, J. P. [6 ]
Contopoulos-Ioannidis, D. G. [7 ]
机构
[1] Local Hlth Unit, Pescara, Italy
[2] Local Hlth Unit, Ferrara, Italy
[3] Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy
[4] Univ Ferrara, Ferrara, Italy
[5] Italian Natl Inst Hlth, Rome, Italy
[6] Stanford Prevent Res Ctr, Stanford, CA USA
[7] Dept Pediat, Stanford, CA USA
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect
    Yara Ruiz García
    Woo-Yun Sohn
    Kate L. Seib
    Muhamed-Kheir Taha
    Julio A. Vázquez
    Ana Paula S. de Lemos
    Kumaran Vadivelu
    Mariagrazia Pizza
    Rino Rappuoli
    Rafik Bekkat-Berkani
    npj Vaccines, 6
  • [22] A new multicomponent vaccine (4CMenB) to protect against serogroup B meningococcal disease. Part 2: Safety and tolerability
    Zwiauer, K. F. M.
    BrOKer, M.
    Banzhoff, A.
    PADIATRIE UND PADOLOGIE, 2014, 49 : 13 - 19
  • [23] Characteristics of YouTube videos about the meningococcal B vaccine (4CMenB)
    Hernandez-Garcia, Ignacio
    Ragozzino, Silvio
    Gimenez-Julvez, Teresa
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (10) : 2513 - 2517
  • [24] A new multicomponent vaccine (4CMenB) to protect against serogroup B invasive meningococcal disease. Part 1: Clinical data on the immunogenicity
    Zwiauer, K. F. M.
    Broker, M.
    Banzhoff, A.
    PADIATRIE UND PADOLOGIE, 2014, 49 : 3 - 12
  • [25] Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials
    Vesikari, Timo
    Esposito, Susanna
    Prymula, Roman
    Ypma, Ellen
    Kohl, Igor
    Toneatto, Daniela
    Dull, Peter
    Kimura, Alan
    LANCET, 2013, 381 (9869): : 825 - 835
  • [26] Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment
    Vogel, Ulrich
    Taha, Muhamed-Kheir
    Vazquez, Julio A.
    Findlow, Jamie
    Claus, Heike
    Stefanelli, Paola
    Caugant, Dominique A.
    Kriz, Paula
    Abad, Raquel
    Bambini, Stefania
    Carannante, Anna
    Deghmane, Ala Eddine
    Fazio, Cecilia
    Frosch, Matthias
    Frosi, Giacomo
    Gilchrist, Stefanie
    Giuliani, Marzia M.
    Hong, Eva
    Ledroit, Morgan
    Lovaglio, Pietro G.
    Lucidarme, Jay
    Musilek, Martin
    Muzzi, Alessandro
    Oksnes, Jan
    Rigat, Fabio
    Orlandi, Luca
    Stella, Maria
    Thompson, Danielle
    Pizza, Mariagrazia
    Rappuoli, Rino
    Serruto, Davide
    Comanducci, Maurizio
    Boccadifuoco, Giuseppe
    Donnelly, John J.
    Medini, Duccio
    Borrow, Ray
    LANCET INFECTIOUS DISEASES, 2013, 13 (05): : 416 - 425
  • [27] Multicomponent Meningococcal Serogroup B Vaccine (4CMenB; Bexsero®): A Review of its Use in Primary and Booster Vaccination
    Natalie J. Carter
    BioDrugs, 2013, 27 : 263 - 274
  • [28] Multicomponent Meningococcal Serogroup B Vaccine (4CMenB; Bexsero®): A Review of its Use in Primary and Booster Vaccination
    Carter, Natalie J.
    BIODRUGS, 2013, 27 (03) : 263 - 274
  • [29] The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigens
    Serruto, Davide
    Bottomley, Matthew J.
    Ram, Sanjay
    Giuliani, Marzia M.
    Rappuoli, Rino
    VACCINE, 2012, 30 : B87 - B97
  • [30] Diversity of greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine
    Georgina Tzanakaki
    Eva Hong
    Konstatinos Kesanopoulos
    Athanasia Xirogianni
    Stefania Bambini
    Luca Orlandi
    Maurizio Comanducci
    Alessandro Muzzi
    Muhamed-Kheir Taha
    BMC Microbiology, 14